372 related articles for article (PubMed ID: 19481695)
21. Novel design of osmotic chitosan capsules characterized by asymmetric membrane structure for in situ formation of delivery orifice.
Wang GM; Chen CH; Ho HO; Wang SS; Sheu MT
Int J Pharm; 2006 Aug; 319(1-2):71-81. PubMed ID: 16701971
[TBL] [Abstract][Full Text] [Related]
22. Evaluation and modification of N-trimethyl chitosan chloride nanoparticles as protein carriers.
Chen F; Zhang ZR; Huang Y
Int J Pharm; 2007 May; 336(1):166-73. PubMed ID: 17145144
[TBL] [Abstract][Full Text] [Related]
23. Electrospray fabrication of doxorubicin-chitosan-tripolyphosphate nanoparticles for delivery of doxorubicin.
Songsurang K; Praphairaksit N; Siraleartmukul K; Muangsin N
Arch Pharm Res; 2011 Apr; 34(4):583-92. PubMed ID: 21544723
[TBL] [Abstract][Full Text] [Related]
24. Cellular uptake mechanism and intracellular fate of hydrophobically modified glycol chitosan nanoparticles.
Nam HY; Kwon SM; Chung H; Lee SY; Kwon SH; Jeon H; Kim Y; Park JH; Kim J; Her S; Oh YK; Kwon IC; Kim K; Jeong SY
J Control Release; 2009 May; 135(3):259-67. PubMed ID: 19331853
[TBL] [Abstract][Full Text] [Related]
25. Enhanced electrostatic interaction between chitosan-modified PLGA nanoparticle and tumor.
Yang R; Shim WS; Cui FD; Cheng G; Han X; Jin QR; Kim DD; Chung SJ; Shim CK
Int J Pharm; 2009 Apr; 371(1-2):142-7. PubMed ID: 19118614
[TBL] [Abstract][Full Text] [Related]
26. Hydrophobically modified glycol chitosan nanoparticles-encapsulated camptothecin enhance the drug stability and tumor targeting in cancer therapy.
Min KH; Park K; Kim YS; Bae SM; Lee S; Jo HG; Park RW; Kim IS; Jeong SY; Kim K; Kwon IC
J Control Release; 2008 May; 127(3):208-18. PubMed ID: 18336946
[TBL] [Abstract][Full Text] [Related]
27. Melatonin-loaded lecithin/chitosan nanoparticles: physicochemical characterisation and permeability through Caco-2 cell monolayers.
Hafner A; Lovrić J; Voinovich D; Filipović-Grcić J
Int J Pharm; 2009 Nov; 381(2):205-13. PubMed ID: 19596430
[TBL] [Abstract][Full Text] [Related]
28. Polymeric nanoparticles of cholesterol-modified glycol chitosan for doxorubicin delivery: preparation and in-vitro and in-vivo characterization.
Yu JM; Li YJ; Qiu LY; Jin Y
J Pharm Pharmacol; 2009 Jun; 61(6):713-9. PubMed ID: 19505361
[TBL] [Abstract][Full Text] [Related]
29. Cetirizine dihydrochloride loaded microparticles design using ionotropic cross-linked chitosan nanoparticles by spray-drying method.
Li FQ; Ji RR; Chen X; You BM; Pan YH; Su JC
Arch Pharm Res; 2010 Dec; 33(12):1967-73. PubMed ID: 21191762
[TBL] [Abstract][Full Text] [Related]
30. Controlled release study of 5-fluorouracil-loaded chitosan/polyethylene glycol microparticles.
Lin CC; Fu CH
Drug Deliv; 2009 Jul; 16(5):274-9. PubMed ID: 19538009
[TBL] [Abstract][Full Text] [Related]
31. Enhanced antiviral activity of Acyclovir loaded into beta-cyclodextrin-poly(4-acryloylmorpholine) conjugate nanoparticles.
Cavalli R; Donalisio M; Civra A; Ferruti P; Ranucci E; Trotta F; Lembo D
J Control Release; 2009 Jul; 137(2):116-22. PubMed ID: 19361545
[TBL] [Abstract][Full Text] [Related]
32. Colorectal cancer cell detection by 5-aminolaevulinic acid-loaded chitosan nano-particles.
Yang SJ; Shieh MJ; Lin FH; Lou PJ; Peng CL; Wei MF; Yao CJ; Lai PS; Young TH
Cancer Lett; 2009 Jan; 273(2):210-20. PubMed ID: 18809246
[TBL] [Abstract][Full Text] [Related]
33. Optimization of fabrication parameters to produce chitosan-tripolyphosphate nanoparticles for delivery of tea catechins.
Hu B; Pan C; Sun Y; Hou Z; Ye H; Zeng X
J Agric Food Chem; 2008 Aug; 56(16):7451-8. PubMed ID: 18627163
[TBL] [Abstract][Full Text] [Related]
34. Multiresponse optimization of the properties of albendazole-chitosan microparticles.
Leonardi D; Lamas MC; Olivieri AC
J Pharm Biomed Anal; 2008 Nov; 48(3):802-7. PubMed ID: 18805667
[TBL] [Abstract][Full Text] [Related]
35. Intravesical cationic nanoparticles of chitosan and polycaprolactone for the delivery of Mitomycin C to bladder tumors.
Bilensoy E; Sarisozen C; Esendağli G; Doğan AL; Aktaş Y; Sen M; Mungan NA
Int J Pharm; 2009 Apr; 371(1-2):170-6. PubMed ID: 19135514
[TBL] [Abstract][Full Text] [Related]
36. In situ preparation of magnetic Fe3O4-chitosan nanoparticles for lipase immobilization by cross-linking and oxidation in aqueous solution.
Wu Y; Wang Y; Luo G; Dai Y
Bioresour Technol; 2009 Jul; 100(14):3459-64. PubMed ID: 19329306
[TBL] [Abstract][Full Text] [Related]
37. Cyclodextrin-insulin complex encapsulated polymethacrylic acid based nanoparticles for oral insulin delivery.
Sajeesh S; Sharma CP
Int J Pharm; 2006 Nov; 325(1-2):147-54. PubMed ID: 16859846
[TBL] [Abstract][Full Text] [Related]
38. Preparation of nanoparticles composed of chitosan/poly-gamma-glutamic acid and evaluation of their permeability through Caco-2 cells.
Lin YH; Chung CK; Chen CT; Liang HF; Chen SC; Sung HW
Biomacromolecules; 2005; 6(2):1104-12. PubMed ID: 15762683
[TBL] [Abstract][Full Text] [Related]
39. Glycyrrhizin surface-modified chitosan nanoparticles for hepatocyte-targeted delivery.
Lin A; Liu Y; Huang Y; Sun J; Wu Z; Zhang X; Ping Q
Int J Pharm; 2008 Jul; 359(1-2):247-53. PubMed ID: 18457928
[TBL] [Abstract][Full Text] [Related]
40. Dexamethasone acetate encapsulation into Trojan particles.
Gómez-Gaete C; Fattal E; Silva L; Besnard M; Tsapis N
J Control Release; 2008 May; 128(1):41-9. PubMed ID: 18374442
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
